ASX Announcements
- September 7th, 2023 - Nuheara Limited (ASX: NUH) Investor Briefing [Video Presentation]
- August 3rd, 2023 - Nuheara Limited (ASX: NUH) Q4 FY23 Webinar [Video Presentation]
- June 6th, 2023 - Nuheara Secures $4.4 Million at a Premium to Accelerate US Market Growth
- April 28th, 2023 - Nuheara Executive Appointments and Restructured Global Team to Maximise Growth Opportunities
- April 28th, 2023 - Nuheara Limited (ASX: NUH) Q3 FY23 Update [Audio Recording]
- February 28th, 2023 - Nuheara Expands with Target.com in the US and Ships HP Hearing PRO
- February 21st, 2023 - Nuheara To Distribute HP Hearing PRO Through Fuel Medical
- February 16th, 2023 - Nuheara Commences Mass Production of HP Hearing PRO with Shipping Expected this Month
- February 8th, 2023 - Quarterly Activities Report and Appendix 4C, 31 December 2022
- December 22nd, 2022 - Nuheara raises over $3 MILLION to underpin US growth. – 22 December 2022
- December 12th, 2022 - Nuheara Expands U.S. Retail Footprint with InnerScope Strategic Partnership – 12 December 2022
- November 2nd, 2022 - Nuheara (NUH) Investor Briefing – SYD Nov 2, 2022 Canberra, Melbourne, Sydney
- October 31st, 2022 - 2023 FY Q1 Results – Webinar 31 October 2022
- October 31st, 2022 - Quarterly Activities Report and Appendix 4C – 31 October 2022
- October 31st, 2022 - NUHEARA RECEIVES HISTORIC FDA CLEARANCE FOR SELF-FITTING OTC HEARING AID AND LAUNCHES HP HEARING PRO
- October 6th, 2022 - 2022 AGM Key Dates – 06 OCTOBER 2022
- September 16th, 2022 - Appendix 3G: Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
- September 5th, 2022 - Nuheara Limited (ASX: NUH) – Suspension from Quotation – 05 September 2022
- September 1st, 2022 - Nuheara Limited ASX:NUH – Trading Halt 01 September 22
- August 23rd, 2022 - Results of General Meeting of Shareholders, 22 August 2022
- August 17th, 2022 - US OTC HEARING AID MARKET TO OPEN FOR NUHEARA
- July 29th, 2022 - Becoming a substantial holder
- July 29th, 2022 - Quarterly Activities and Cash Flow Report – quarter ended 30 June 2022
- July 27th, 2022 - s708A Cleansing Notice
- July 27th, 2022 - Appendix 2A – Application for the Quotation of Shares
- July 27th, 2022 - Notice of Initial Substantial Holder
- July 22nd, 2022 - APPOINTMENT OF AUDITOR
- July 21st, 2022 - NOTICE OF GENERAL MEETING AND EXPLANATORY MEMORANDUM TO SHAREHOLDERS
- July 21st, 2022 - GENERAL MEETING – NOTICE AND PROXY FORM
- July 19th, 2022 - Appendix 2A: Bergen Share Issue
- July 19th, 2022 - Appendix 2A: Directors’ Salary Sacrifice Shares
- July 19th, 2022 - Appendix- 2A Realtek
- July 16th, 2022 - Appendix 3Y: Change of Directors’ Interest Notice x 4
- July 16th, 2022 - Sec 708A Cleansing Notice
- July 16th, 2022 - Sec 708A Cleansing Notice
- July 16th, 2022 - Appendix 2A: Directors’ Salary Sacrifice Shares
- July 16th, 2022 - Appendix 2A: Bergen Share Issue
- July 16th, 2022 - Appendix 2A: Realtek Shares
- July 6th, 2022 - Notification of cessation of securities – NUH
- July 1st, 2022 - Section 708A(5)(e) Notice
- July 1st, 2022 - NUH Strategic Partner & Cornerstone Investment with Realtek
- July 1st, 2022 - Reinstatement to Official Quotation
- July 1st, 2022 - Application for quotation of securities – NUH
- June 8th, 2022 - Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
- May 25th, 2022 - AGREEMENT FOR THE SALE OF NON-CORE MINING ROYALTY[42]
- May 24th, 2022 - Appendix 4C: Quarter Ended 31 March 2022 – Amended
- May 9th, 2022 - Nuheara Announces New CEO and Roth Capital to Explore US Listing
- May 3rd, 2022 - 2022 FY Q3 Results – Webinar & Presentation Slides
- May 3rd, 2022 - Quarterly Activities Report and Appendix 4C
- April 29th, 2022 - Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
- April 27th, 2022 - RESULTS OF GENERAL MEETING OF SHAREHOLDERS
- April 27th, 2022 - Section 708A(5)(e) Notice
- April 27th, 2022 - Appendix 2A – Application for Quotation of Securities
- April 26th, 2022 - Nuheara Enters Worldwide Trademark License Agreement With HP Inc.
- April 12th, 2022 - NUHEARA SUBMITS 510(k) FOR U.S. FDA CLEARANCE
- March 28th, 2022 - NUH – Notification of Consolidation/Split
- March 25th, 2022 - NUH EGM Letter to Shareholders – Notice of Meeting and Proxy Form
- March 25th, 2022 - NOTICE OF GENERAL MEETING AND EXPLANATORY MEMORANDUM TO SHAREHOLDERS
- March 25th, 2022 - Appendix 3H Notification of Cessation of Securities
- February 28th, 2022 - Half Year Ended 31 December 2021 – Nuheara Well Placed To Grow
- February 16th, 2022 - NUHEARA EXPANDS US OPERATIONS TO CAPTURE REGULATED HEARING MARKET OPPORTUNITY
- February 9th, 2022 - S708A(5)(e) Cleansing Notice
- February 9th, 2022 - Appendix 2A – Application for Quotation of Securities
- February 1st, 2022 - 2022FY Q2 Results – Webinar & Presentation Slides
- February 1st, 2022 - Clinical Trial Validates Hearing Benefits of Nuheara’s Self-Fitted Hearing Aids & Software
- January 31st, 2022 - Quarterly Activities Report – For the quarter ended 31 December 2021
- January 28th, 2022 - Q2 FY22 Business Update and Investor Briefing Details
- January 28th, 2022 - Appendix 3Y – Change of Director’s Interest Notice
- January 25th, 2022 - Appendix 2A – Application for quotation of securities
- January 24th, 2022 - Nuheara Completes Share Purchase Plan
- January 6th, 2022 - Nuheara Clinical Trial and FDA 510(K) Pathway Update
- January 5th, 2022 - Section 708A(5)(e) Notice (cleansing notice)
- January 5th, 2022 - Appendix 2A – Application for quotation of securities
- January 4th, 2022 - Appendix 3B – CN Cap Raising & SPP_231221
- January 4th, 2022 - Nuheara Undertakes Capital Raising to Support Growth